Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
about
Advances in Primary Central Nervous System Lymphoma.Herpes simplex encephalitis and subsequent cytomegalovirus encephalitis after chemoradiotherapy for central nervous system lymphoma: a case report and literature review.Imaging 'the lost tribe': a review of adolescent cancer imaging. Part 2: imaging of complications of cancer treatment.Non-enhancing relapse of a primary CNS lymphoma with multiple diffusion-restricted lesions.Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell TransplantationCognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia.Cancer therapy-associated CNS neuropathology: an update and review of the literature.Assessing neurocognitive dysfunction in cranial radiotherapy: can cognitive event-related potentials help?Neurologic toxicities of cancer therapies.Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.Central and peripheral nervous system toxicity of common chemotherapeutic agents.Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy.Diagnosis and treatment of primary CNS lymphoma.Differential diagnosis of white matter lesions: Nonvascular causes-Part II.Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma.Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direMethotrexate-related leukoencephalopathy without radiation therapy: distribution of brain lesions and pathological heterogeneity on two autopsy cases.Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments.Diagnosis and management of primary central nervous system lymphoma.Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma.Chemotherapy-related magnetic resonance imaging abnormalities mimicking disease progression following intraventricular liposomal cytarabine and high dose methotrexate for neurolymphomatosis.[Cognitive deficits following brain tumor radiation therapy].A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.Primary central nervous system lymphoma
P2860
Q31007237-59345FDE-028D-4902-89E5-11261F94D056Q31152730-44835212-82EC-4BB9-BDC2-5B01BEABC630Q33516446-7D0DA33F-7DAE-4688-B171-2A5C0140D88FQ33625147-527F5A85-FCD4-4A19-9931-AD7EDA763629Q33679931-82CD9BDF-7280-45F9-A121-D958AF1A3C7BQ34021952-AF4CBE12-E96A-4226-91E0-4E726E92A667Q34036804-7C53B1FF-BE53-4B69-9710-22C528BDB59CQ35627088-BF8233D2-B6BC-45FC-87CE-028BFB7215B2Q36389377-1065F751-B505-4596-83A2-08250E89F719Q36427234-B39B8AC6-16DD-4F65-867C-79EB79E369A7Q36458738-92C92001-D12E-4DB1-B72A-3B1B87A0B3FFQ37280734-3A5F2D85-62CD-471D-B2E4-35AC238BD383Q37284222-0E624F44-41AA-4E77-B3CC-AA87647794EFQ37335100-E850E500-1647-4399-9395-5CC0C5E813FAQ37987088-F09DD82B-8D2F-44AF-BB56-8C1E7EFA45C9Q38106613-77811D71-BA82-4ABE-B07A-B7E633FDC356Q38187363-5477A710-4244-422F-980F-1E864C8D18C4Q41593361-8B3FA52A-0A58-4910-BC35-D042E47590E0Q43178514-E467ADE5-CA45-4B44-97E7-3BEADA61822CQ46483522-1B035EC4-F76E-4899-A7D2-EBC024E6A5DEQ46494188-E616335C-21FA-4BEC-9D1D-3E512F14CD53Q48095976-5FBB6192-A58E-4077-A9B1-D798E899B4F6Q48140146-B1A8B41C-E312-41A2-9D56-BDF730DAEBBCQ48714811-E3AB48C1-2119-4BBF-95FB-E522BAC504F8Q49971341-ED4AF1EF-0FF6-4277-8457-2C2D7B87D04EQ51446765-51C63D39-721F-4085-8F38-621A0BE732CEQ57297768-F9A326CB-B0C4-46DB-AD5B-4F381A613BD1
P2860
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Treatment-induced leukoencepha ...... a clinical and autopsy study.
@ast
Treatment-induced leukoencepha ...... a clinical and autopsy study.
@en
type
label
Treatment-induced leukoencepha ...... a clinical and autopsy study.
@ast
Treatment-induced leukoencepha ...... a clinical and autopsy study.
@en
prefLabel
Treatment-induced leukoencepha ...... a clinical and autopsy study.
@ast
Treatment-induced leukoencepha ...... a clinical and autopsy study.
@en
P2093
P1433
P1476
Treatment-induced leukoencepha ...... : a clinical and autopsy study
@en
P2093
Lauren E Abrey
Marc K Rosenblum
P304
P356
10.1212/01.WNL.0000106941.51340.A2
P407
P577
2004-02-01T00:00:00Z